NDT
@ndt-era.bsky.social
Nephrology Dialysis Transplantation (NDT) is the leading nephrology journal in Europe. NDT is an official journal of the European Renal Association and is published by Oxford University Press.
Urinary dipstick findings and UTI risk with SGLT2 inhibitors: a post hoc analysis of the CANVAS and CREDENCE trials doi.org/10.1093/ndt/...
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications doi.org/10.1093/ndt/...
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications
ABSTRACT. The discovery of circulating autoantibodies targeting slit diaphragm proteins—particularly nephrin, podocin and Kirrel1—has redefined the pathoge
doi.org
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD doi.org/10.1093/ndt/...
Evolving strategies for early diagnosis, proactive prevention and treatment of CKD
ABSTRACT. Chronic kidney disease (CKD) is among the fastest growing global causes of death, forecasted to become the third leading cause of death in Wester
doi.org
Management of monoclonal gammopathy of renal significance: treatment standard doi.org/10.1093/ndt/...
Management of monoclonal gammopathy of renal significance: treatment standard
ABSTRACT. Monoclonal gammopathy of renal significance (MGRS) is a heterogeneous group of clonal B cell or plasma cell proliferative disorders that cause ki
doi.org
😍 Check out the new March issue of NDT! academic.oup.com/ndt/issue
Issues | Nephrology Dialysis Transplantation | Oxford Academic
An official journal of the European Renal Association - European Dialysis and Transplant Association. Publishes peer-reviewed original clinical and laboratory research across the full range of nephrol...
academic.oup.com
The updated global burden of chronic kidney disease: one death every 20 seconds doi.org/10.1093/ndt/...
The updated global burden of chronic kidney disease: one death every 20 seconds
Abstract. In 2024, Global Burden of Disease (GBD) updated the forecast of global cause-specific age-standardized death rates. Chronic kidney disease (CKD)
doi.org
What do clinical trials teach us about the pathophysiology of human IgA nephropathy? 🆓 doi.org/10.1093/ndt/...
😍Did you already discover the NDT kidney art gallery? era-online.org/ndt-kidney-a... 🤩Check it out and send us one of your own kidney images!
🤩 Check out the new January issue of NDT! academic.oup.com/ndt/issue/41/1
Volume 41 Issue 1 | Nephrology Dialysis Transplantation | Oxford Academic
An official journal of the European Renal Association - European Dialysis and Transplant Association. Publishes peer-reviewed original clinical and laboratory research across the full range of nephrol...
academic.oup.com
Anti-glomerular basement membrane disease—treatment standard doi.org/10.1093/ndt/...
Anti-glomerular basement membrane disease—treatment standard
ABSTRACT. We review the current standards of treatment and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management
doi.org
How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA doi.org/10.1093/ndt/...
How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA
ABSTRACT. The interrelated pandemics of obesity and type 2 diabetes mellitus (T2DM) are fuelling an increase in the prevalence of chronic kidney disease (C
doi.org
When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice doi.org/10.1093/ndt/...
When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice
ABSTRACT. Patients with kidney disease have an uncertain future, with prognosis varying greatly per patient. To get a better idea of what the future holds
doi.org
How should we best manage the consequences of nephron loss in IgAN? doi.org/10.1093/ndt/...
How should we best manage the consequences of nephron loss in IgAN?
Jackson Kim, Fahmeedah Kamal, Brittany Yeung, Richard Lafayette; How should we best manage the consequences of nephron loss in IgAN?, Nephrology Dialysis T
doi.org
BK Polyomavirus-associated nephropathy – diagnostic and treatment standard 🆓 doi.org/10.1093/ndt/...
BK Polyomavirus-associated nephropathy – diagnostic and treatment standard
ABSTRACT. BK polyomavirus (BKPyV) is recognized as a significant viral complication of kidney transplantation. Prompt immunosuppression reduction reduces e
doi.org
Global, regional, and national burden of renal anemia, 1990 to 2019 and prediction to 2050 doi.org/10.1093/ndt/...
Prevalence of reduced eGFR in European adults using KDIGO and age-adapted eGFR thresholds doi.org/10.1093/ndt/...
The nonsteroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria doi.org/10.1093/ndt/...
Management of monoclonal gammopathy of renal significance: treatment standard doi.org/10.1093/ndt/...
Management of monoclonal gammopathy of renal significance: treatment standard
Abstract. Monoclonal gammopathy of renal significance (MGRS) is a heterogeneous group of clonal B-cell or plasma cell proliferative disorders that cause ki
doi.org
Kidney disease after hematopoietic stem cell transplant —treatment standard doi.org/10.1093/ndt/...
Kidney disease after hematopoietic stem cell transplant—treatment standard
ABSTRACT. Hematopoietic stem cell transplant (HSCT) is a well-established procedure for malignant and nonmalignant conditions. Despite its therapeutic bene
doi.org
Now online in @ndt-era.bsky.social – this article by Prof Daniel Gale shows how RaDaR data are accelerating drug development for rare kidney diseases – informing NICE appraisals, regulatory endpoints & clinical trials for IgA nephropathy, FSGS, C3G & Alport syndrome. 📄: ow.ly/L9HK50XqqqT
